Spotlight
Clinical
News
FDA
CME/CE
First-time generic approvals
Methscopolamine tablets, 2.5 mg (equiv to Pamine tablets)
Methscopolamine tablets, 2.5 mg (equiv to Pamine tablets)
BOCA PHARMACAL
Methscopolamine tablets, 5 mg (equiv to Pamine Forte tablets)
BOCA PHARMACAL
Bupropion extended-release tablets, 150 and 300 mg (equiv to Wellbutrin XL extended-release tablets)
ANCHEN
Ondansetron orally disintegrating tablets, 4, 8, 16, and 24 mg (equiv to Zofran orally disintegrating tablets)
KALI
Ondansetron oral solution, 4 mg (base)/5 mL (equiv to Zofran oral solution)
ROXANE
Albuterol and ipratropium inhalation solution, 3 mg (0.083%) and 0.5 mg (0.017%) in 3-mL vials (equiv to DuoNeb inhalation solution)
SANDOZ
Related Content
